These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight. Mylonaki I; Allémann E; Delie F; Jordan O J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251 [TBL] [Abstract][Full Text] [Related]
6. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends. Wang T; Xue P; Wang A; Yin M; Han J; Tang S; Liang R Eur J Pharm Sci; 2019 Oct; 138():104990. PubMed ID: 31302216 [TBL] [Abstract][Full Text] [Related]
7. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
8. Porous PLGA microparticles prepared with nanosized/micronized sugar particles as porogens. Zhang C; Bodmeier R Int J Pharm; 2024 Jul; 660():124329. PubMed ID: 38857662 [TBL] [Abstract][Full Text] [Related]
9. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies. Gasmi H; Danede F; Siepmann J; Siepmann F J Control Release; 2015 Sep; 213():120-127. PubMed ID: 26150116 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery. Haddadi A; Farboud ES; Erfan M; Aboofazeli R J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885 [TBL] [Abstract][Full Text] [Related]
11. Development and Evaluation of Ropivacaine Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres with Low Burst Release. Zhao X; Gao Y; Tang X; Lei W; Yang Y; Yu F; Liu Y; Yang M; Wang Y; Gong W; Li Z; Gao C; Mei X Curr Drug Deliv; 2019; 16(6):490-499. PubMed ID: 31132975 [TBL] [Abstract][Full Text] [Related]
12. Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying. Wan F; Bohr A; Maltesen MJ; Bjerregaard S; Foged C; Rantanen J; Yang M Pharm Res; 2013 Apr; 30(4):1065-76. PubMed ID: 23263784 [TBL] [Abstract][Full Text] [Related]
14. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of burst release from pH-responsive polymeric microparticles. Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486 [TBL] [Abstract][Full Text] [Related]
16. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
17. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338 [TBL] [Abstract][Full Text] [Related]
18. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications. Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976 [TBL] [Abstract][Full Text] [Related]